News | May 06, 2025
Alembic Pharmaceuticals posts Q4 FY25 consolidated PAT at Rs. 156.63 Cr
The company has posted net profit of Rs. 582.01 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs. 582.01 crores for the Financial Year ended March 31, 2025
This outcome reflects Innoxel Lifesciences' ongoing commitment to maintaining the highest standards of quality, compliance, and regulatory excellence
Tatva Chintan Pharma Chem receives export order worth $35, 55,000
Gelhaus has a proven track record of driving business growth
Topiramate is indicated as a treatment of epilepsy and migraine
The company has posted net loss of Rs. 17.97 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs. 158.71 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs.5.71 crores for the Financial Year ended March 31, 2025
Express Scripts has added YESINTEK to the National Preferred Formulary (NPF) effective March 21, 2025
The portfolio consists of liquids and immediate release solid orals which are in the therapeutic segment to treat infections associated with UTIs
Subscribe To Our Newsletter & Stay Updated
